Oncolytics Biotech INC (ONCY) — 6-K Filings

All 6-K filings from Oncolytics Biotech INC. Browse 50 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (50)

6-K Filing — Dec 16, 2025
Oncolytics Biotech Reschedules AGM for Audited Financials — Dec 10, 2025 Risk: medium
Oncolytics Biotech Inc. has rescheduled its annual general meeting of shareholders to December 19, 2025. The meeting will now take place at 10:00 AM PST and wil
Oncolytics Biotech Inc. Files 6-K Update — Nov 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 20, 2025, reporting as a foreign private issuer. The filing provides an update related to a special meeting
Oncolytics Biotech Files 6-K — Nov 19, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 19, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive off
Oncolytics Biotech Files Routine 6-K Report — Nov 12, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 12, 2025, reporting for the period ending September 30, 2025. The company, based in Calgary, Canada, is a f
Oncolytics Biotech Files 6-K — Nov 4, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 4, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files 6-K — Oct 28, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 28, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files 6-K — Oct 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 20, 2025, reporting as a foreign private issuer. The filing indicates the company's principal executive offi
Oncolytics Biotech Files October 6-K Report — Oct 20, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 20, 2025, for the month of October 2025. The company is a foreign private issuer based in Calgary, Alberta,
Oncolytics Biotech Files October 2025 6-K Report — Oct 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 10, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved
Oncolytics Biotech Files 6-K — Sep 29, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 29, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a phar
Oncolytics Biotech Inc. Files 6-K Report — Sep 16, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 16, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a phar
Oncolytics Biotech Inc. Files 6-K Report — Sep 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 8, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Files Routine 6-K Report — Sep 2, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 2, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the
Oncolytics Biotech Inc. Files Routine 6-K Report — Aug 28, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 28, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is subject t
Oncolytics Biotech Inc. Files 6-K Report — Aug 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 11, 2025, reporting its status as a foreign private issuer. The company is based in Calgary, Alberta, Canada,
Oncolytics Biotech Inc. Files Routine 6-K Report — Aug 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 8, 2025, reporting for the period ending June 30, 2025. The company, based in Calgary, Alberta, Canada, is a
Oncolytics Biotech Inc. Files 6-K with Incorporated Information Circular — Aug 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 8, 2025, incorporating by reference an Information Circular from a previous filing on July 8, 2025. This circ
Oncolytics Biotech Inc. Files 6-K Report — Aug 5, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 5, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Pha
Oncolytics Biotech Files 6-K Report — Jul 29, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 29, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is involved in
Oncolytics Biotech Files 6-K Report — Jul 23, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 23, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the Phar
Oncolytics Biotech Inc. Files 6-K Report — Jul 22, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 22, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceu
Oncolytics Biotech Files 6-K Report — Jul 16, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 16, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmaceu
Oncolytics Biotech Inc. Files 6-K Report — Jul 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 10, 2025, reporting as a foreign private issuer for the month of July 2025. The company is based in Calgary, Al
Oncolytics Biotech Inc. Files 6-K Report — Jul 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on July 8, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Inc. Files June 2025 6-K Report — Jun 30, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on June 30, 2025, reporting for the month of June 2025. The company, based in Calgary, Alberta, Canada, is a foreign pr
Oncolytics Biotech Inc. Files 6-K Report — Jun 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on June 11, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Inc. Files 6-K Report — May 23, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 23, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates
Oncolytics Biotech Files May 2025 Financial Report — May 14, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 14, 2025, reporting its financial results for the month of May 2025. The company is a foreign private issuer bas
Oncolytics Biotech Inc. Files May 2025 6-K Report — May 8, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on May 8, 2025, reporting for the month of May 2025. The company is a foreign private issuer based in Calgary, Alberta,
Oncolytics Biotech Files 6-K — Apr 24, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 24, 2025, reporting as a foreign private issuer. The filing indicates the company is based in Calgary, Alberta
Oncolytics Biotech Inc. Files April 2025 6-K Report — Apr 11, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 11, 2025, reporting for the month of April 2025. The company is a foreign private issuer based in Calgary, Alb
Oncolytics Biotech Files 6-K Report — Apr 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on April 10, 2025, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is a pharmace
Oncolytics Biotech Enters Purchase Agreement — Apr 10, 2025 Risk: low
On April 10, 2025, Oncolytics Biotech Inc. entered into a purchase agreement with Alumni Capital LP. This filing incorporates the purchase agreement as Exhibit
Oncolytics Biotech Files 6-K Report — Mar 7, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on March 7, 2025, reporting as a foreign private issuer. The filing indicates the company is submitting its report unde
Oncolytics Biotech Files 6-K — Feb 25, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 25, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Inc. Files February 2025 6-K Report — Feb 19, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 19, 2025, reporting for the month of February 2025. The company is a foreign private issuer based in Calgar
Oncolytics Biotech Files February 2025 6-K Report — Feb 18, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 18, 2025, reporting for the month of February 2025. The company, based in Calgary, Alberta, Canada, is a fo
Oncolytics Biotech Inc. Files 6-K Report — Feb 14, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 14, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and its
Oncolytics Biotech Files 6-K for February 2025 — Feb 10, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on February 10, 2025, reporting for the month of February 2025. The company is a foreign private issuer based in Calgar
Oncolytics Biotech Files 6-K Report — Jan 22, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on January 22, 2025, reporting as a foreign private issuer for the month of January 2025. The company is based in Calga
Oncolytics Biotech Inc. Files 6-K — Jan 15, 2025 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on January 15, 2025, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and opera
Oncolytics Biotech Files 6-K Report — Dec 23, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on December 23, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Files 6-K — Dec 18, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on December 18, 2024, reporting as a foreign private issuer for the month of December 2024. The company is based in Cal
Oncolytics Biotech Files Routine 6-K Report — Dec 3, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on December 3, 2024, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is in the P
Oncolytics Biotech Files Form 6-K — Nov 12, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on November 12, 2024, to report information for the month of November 2024. The company is a foreign private issuer bas
Oncolytics Biotech Inc. Files October 2024 6-K Update — Oct 4, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on October 4, 2024, reporting as a foreign private issuer. The company, based in Calgary, Alberta, Canada, is primarily
Oncolytics Biotech Files 6-K Report — Sep 19, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 19, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and ope
Oncolytics Biotech Files 6-K Report — Sep 6, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on September 6, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and oper
Oncolytics Biotech Files 6-K — Aug 2, 2024 Risk: low
Oncolytics Biotech Inc. filed a Form 6-K on August 2, 2024, reporting as a foreign private issuer for the month of August 2024. The company is based in Calgary,

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX